CreakyJoints featuring Kyriakos A. Kirou, MD, DSc, FACP, and Medha Barbhaiya, MD, MPH

Rheumatology Network featuring Kyriakos A. Kirou, MD, DSc, FACP

On August 2, 2021, the US Food and Drug Administration approved the drug anifrolumab (Saphnelo) for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy. Much of the groundwork …

Philly Voice featuring Mary K. Crow, MD and Kyriakos A. Kirou, MD, DSc, FACP

Can krill oil improve the quality of life of people living with systemic lupus erythematous? A clinical trial, involving 20 centers in the United States, is currently enrolling patients to answer this question. Hospital for Special Surgery (HSS), in …

According to a recent study, the monoclonal antibody epratuzumab could deplete B-cells in patients with concomitant systemic lupus erythematosus (SLE) and Sjogren's syndrome, MedPage Today reported. HSS rheumatologist Kyriakos A. Kirou, MD, DSc, …

Rheumatic diseases affect women two to four times more often than men. Studying the sex differences in autoimmune conditions has been the focus of the Barbara Volcker Center for Women and Rheumatic Diseases at Hospital for Special Surgery. In a …